- Home
- VMAR vs CNSP Comparison
VMAR vs CNSP Comparison
Compare VMAR & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VMAR
- CNSP
- Stock Information
- Founded
- VMAR 1995
- CNSP 2017
- Country
- VMAR Canada
- CNSP United States
- Employees
- VMAR N/A
- CNSP N/A
- Industry
- VMAR Marine Transportation
- CNSP Biotechnology: Pharmaceutical Preparations
- Sector
- VMAR Industrials
- CNSP Health Care
- Exchange
- VMAR Nasdaq
- CNSP Nasdaq
- Market Cap
- VMAR 4.5M
- CNSP 4.0M
- IPO Year
- VMAR 2020
- CNSP 2019
- Fundamental
- Price
- VMAR $1.42
- CNSP $7.23
- Analyst Decision
- VMAR
- CNSP Strong Buy
- Analyst Count
- VMAR 0
- CNSP 1
- Target Price
- VMAR N/A
- CNSP $20.00
- AVG Volume (30 Days)
- VMAR 151.8K
- CNSP 25.1K
- Earning Date
- VMAR 12-01-2025
- CNSP 11-12-2025
- Dividend Yield
- VMAR N/A
- CNSP N/A
- EPS Growth
- VMAR N/A
- CNSP N/A
- EPS
- VMAR N/A
- CNSP N/A
- Revenue
- VMAR $1,128,568.00
- CNSP N/A
- Revenue This Year
- VMAR N/A
- CNSP N/A
- Revenue Next Year
- VMAR $264.29
- CNSP N/A
- P/E Ratio
- VMAR N/A
- CNSP N/A
- Revenue Growth
- VMAR N/A
- CNSP N/A
- 52 Week Low
- VMAR $1.25
- CNSP $4.93
- 52 Week High
- VMAR $40.70
- CNSP $114.00
- Technical
- Relative Strength Index (RSI)
- VMAR 40.17
- CNSP 35.31
- Support Level
- VMAR $1.37
- CNSP $8.09
- Resistance Level
- VMAR $1.58
- CNSP $7.70
- Average True Range (ATR)
- VMAR 0.10
- CNSP 0.42
- MACD
- VMAR 0.01
- CNSP -0.27
- Stochastic Oscillator
- VMAR 17.72
- CNSP 0.01
About VMAR Vision Marine Technologies Inc.
Vision Marine Technologies Inc is in the business of designing and manufacturing electric outboard powertrain systems, power boats, and related technology and the renting of electric boats. The different models of the powerboats and electric boats manufactured by the company include Bruce 22, Fantail 217, Volt 180, and others. The company operates in two reportable business segments; Sale of electric boats and Rental of electric boats. The majority of the revenue for the company is generated from the Sale of electric boats segment. Geographically, the company generates revenue from its business in Canada, USA and other countries. A substantial portion of the overall revenue is generated from its business in USA.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.